A 2023 shortage of the generic platinum-based chemotherapy drugs cisplatin and carboplatin had no effect on cancer mortality rates, according to a study published Dec. 3 in the Journal of the National Cancer Institute.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
